ORIGINAL INVESTIGATION. DNA Repair in Lymphoblastoid Cell Lines From Patients With Head and Neck Cancer. genes.
|
|
- Candice Claribel Pierce
- 5 years ago
- Views:
Transcription
1 ORIGINAL INVESTIGATION DNA Repair in Lymphoblastoid Cell Lines From Patients With Head and Neck Cancer Erich M. Sturgis, MD; Gary L. Clayman, DDS, MD; Yongli Guan, BA; Zhaozheng Guo, MD; Qingyi Wei, MD, PhD Objective: To analyze and compare components of the 3 primary DNA repair pathways of Epstein-Barr virus transformed lymphocyte (lymphoblastoid) cell lines derived from 9 patients with squamous cell carcinoma of the head and neck and 11 cancer-free controls. These cell lines were previously characterized by using an established cytogenetic marker of cancer susceptibility (mutagen sensitivity assay). Design: To evaluate nucleotide excision repair (NER), we measured the reactivation level of a tobacco carcinogen damaged plasmid containing a bacterial reporter gene transfected into these cells. To assess mismatch repair (MMR) and recombinational repair, selected gene transcript levels were quantified by using a multiplex reverse transcriptase polymerase chain reaction assay. The results of these DNA repair assays were correlated with the previously measured mutagen sensitivity values. Results: The NER capacities of the 2 groups were similar: 25.1% (range, 14.3%-33.3%) for the patient cell lines and 26.% (range, 9.4%-47.7%) for the control lines. Transcriptase levels for 6 MMR genes (hmsh3, hmsh2, hpms2, GTBP, hmlh1, and hpms1) did not differ in the 2 groups. Transcript levels for 4 of 6 recombinational repair genes (XRCC7, XRCC6, XRCC1, and RAD51) were higher in the patient cell lines, though this difference was significant only for XRCC7 (P =.3). The mutagen sensitivity values correlated with the NER capacity (P =.5) and the expression of XRCC4 (P =.l) and RAD51 (P =.6) genes. Conclusions: As revealed by the above-named assays, these lymphoblastoid cell lines derived from patients with head and neck cancer had minor alterations in DNA repair function. However, these differences in DNA repair do appear to affect the cytogenetic marker of cancer susceptibility, mutagen sensitivity. Arch Otolaryngol Head Neck Surg. 1999;125: From the Departments of Head and Neck Surgery (Drs Sturgis and Clayman) and Epidemiology (Ms Guan and Drs Guo and Wei), the University of Texas, M. D. Anderson Cancer Center, Houston. APPROXIMATELY 46 million adult Americans smoke, 1 yet only a small fraction (41 ) develop squamous cell carcinoma of the head and neck (SCCHN) annually. 2 One would presume that differences in susceptibility to tobacco-induced carcinogenesis partially underlie the disparity between those exposed and those who ultimately develop cancer. Others have suggested that cancer susceptibility has an etiologic role in the development of SCCHN at a young age 3 and in patients without tobacco or alcohol exposure. 4 A genetic source for these differences in susceptibility has been implied in family studies of SCCHN. 5-8 These studies have demonstrated a significantly increased relative risk (3.- to 3.8-fold) for developing an SCCHN in persons having a first-degree relative with SCCHN. The field of ecogenetics encompasses such genetic variations (polymorphisms) in response to carcinogen exposure, and differences in carcinogen metabolism and DNA repair ability have been suggested to underlie such genetic susceptibility. While several case-control studies have examined the risk of SCCHN in individuals with genetic variants of the phase I and phase II carcinogen-metabolizing genes, only minor increases in risk have been demonstrated. 9,1 Differences in DNA repair ability may provide a better risk estimate. Bleomycin-induced mutagen sensitivity, an in vitro phenotypic marker of cancer susceptibility, is believed to reflect genetically determined differences in DNA repair ability. 11,12 In this assay, peripheral blood lymphocytes grown in culture are exposed to the mutagen, bleomycin. Then, cytogenetic analysis is performed to quantify induced chromatid breaks. Multiple case-control studies have been performed in patients with lung cancer and SCCHN and have demonstrated a consistently higher number of 185
2 MATERIALS AND METHODS CELL LINES Twenty lymphoblastoid cell lines were obtained from T. C. Hsu, PhD (Department of Cell Biology, M. D. Anderson Cancer Center, Houston, Tex). The establishment and characterization of these cell lines has been described elsewhere. 16 Briefly, these cell lines were established by Epstein- Barr virus transformation of peripheral blood lymphocytes obtained from 9 patients with SCCHN and 11 cancerfree donors. The bleomycin mutagen sensitivity assay, a cytogenetic marker of cancer susceptibility, had been performed previously 1 time on each original blood sample and 4 times on each transformed cell line. As the values obtained from the cell lines correlated with those of the original blood samples (r =.7), these cell lines were believed by Hsu et al 16 to phenotypically represent the original subjects. Three additional Epstein-Barr virus immortalized human lymphoblastoid cell lines were used for controls: the normal cell line GM13lA and 2 xeroderma pigmentosum (XP) cell lines, GM2345B (XP-A) and GM2246B (XP-C) (Human Genetic Mutant Cell Repository, Camden, NJ). Two colon cancer lines that have deficient mismatch repair were also used for controls: LoVo (229- CCL), which has mutations in the hmsh2 gene, and SW48 (231-CCL), which has mutations in the hmlh1 gene (American Type Culture Collection, Rockville, Md). The lymphoblastoid cell lines were maintained in RPMI 164 medium with 15% fetal bovine serum, 1% L-glutamine, and 1% penicillin/streptomycin combination. The LoVo was maintained in Ham F 12 medium with 2% fetal bovine serum and 1% penicillin/streptomycin combination. The SW48 was maintained in Liebovitz L15 medium with 1% fetal bovine serum and 1% penicillin/streptomycin. All cells were incubated at 37 C in a 5% carbon dioxide atmosphere except for SW48, which was maintained without carbon dioxide. HOST CELL REACTIVATION ASSAY This assay has been described in detail elsewhere 12,17,18 and was used as a measure of nucleotide excision repair (NER). The plasmid (5 µg/ml pcmvcat, a gift from Lawrence Grossman, PhD, The Johns Hopkins University, Baltimore, Md) was treated as previously described 18 with the or 6 µmol of activated tobacco carcinogen benzo[a]pyrene diol epoxide (BPDE) per liter for 3 hours in a dark room. Then, the plasmids were precipitated 3 times in 7% ethanol, dissolved in Tris-EDTA buffer to yield a final 5-µg/mL concentration, and checked for conformational changes on a.8% agarose gel. The BPDE forms adducts with the plasmid, preventing chloramphenicol acetyltransferase gene transcription, and these adducts are removed by the NER pathway. 17,18 Aliquots of treated plasmid were stored at 8 C until used, and all plasmids used in this study were from a single treatment. For transfection, cells from an early passage of each cell line growing approximately the same density and in the same medium conditions were washed in Tris- EDTA buffered saline solution with calcium (.7 µmol/l) and magnesium (.5 µmol/l) and transfected with treated and untreated plasmid by using the diethylyaminoethyldextran (Pharmacia Biotech Inc, Piscataway, NJ) method. 19 Triplicate transfections were performed with both treated and untreated plasmid. Chloramphenicol acetyltransferase gene expression (and thus NER capacity) was measured 4 hours after transfection as described elsewhere. 17 The assay was performed in triplicate or quadruplicate for each cell line. The normal cell line GM13lA was used as a negative (NER-proficient) control, and the 2 (XP) cell lines GM2345B (XP-A) and GM2246B (XP-C) were used as positive (NER-deficient) controls. MULTIPLEX REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION (RT-PCR) As described elsewhere, 2,21 total RNA was isolated from 5 l 6 cells by using Tri-Reagent, an RNA-DNA-protein isolation reagent (Molecular Research Center Inc, Cincinnati, Ohio), according to the manufacturer s protocol. The RNA was quantified by spectrophotometry. Complementary DNA was synthesized by reverse transcription from 5 µg of RNA by using random primers. Multiplex PCR was performed in triplicate using 5 µl of the complementary DNA product and specific primers for 6 mismatch repair (MMR) genes (hmsh3, hmsh2, hpms2, GTBP, hmlh1, and hpms1) and -actin. The -actin was used as a loading control and internal standard for transcript quantification. After gel electrophoresis separation of the PCR products, computer densitometry was used to calculate the relative level of each band on the gel by comparison with that of the ubiquitous -actin. These RNA samples were then analyzed using a multiplex-pcr system designed to measure the transcripts of 5 genes involved in recombinational repair (XRCC7, XRCC6, XRCC1, RAD51, and XRCC4) and the A TM gene transcript. Initially, as previously, 2,21 the primer cocktails used in both of these PCR assays were fully characterized (Figure 1). After 3 dose-curve analyses of various amounts of pooled RNA, 5 µg of RNA was chosen for complementary DNA synthesis because it ensured maximum amplification and quality of RT-PCR products (data not shown). Three dose-curve analyses were also performed by using increasing amounts of pooled complementary DNA product, 5 µl of which was subsequently used for all multiplex PCRs, again owing to the consistent quality and amplification of the products (data not shown). Nuclease-free water, a normal cell line (GM131A), and 2 colon cancer lines (LoVo, which has mutations in the hmsh2 gene, and SW48, which has mutations in the hmlh1 gene) were used for negative, normal (proficient), and positive (deficient) controls, respectively. STATISTICAL ANALYSIS The measurements for NER capacity, MMR transcript levels, and recombinational repair transcript levels were analyzed as continuous variables. The Student t test was used to compare values for the group of cell lines derived from patients and those derived from cancer-free donors. Correlation analyses were performed between values of each of the 3 DNA repair assays and the mutagen sensitivity values. For the MMR and recombinational repair assays, the correlation analyses were performed first with each individual gene transcript level and then with the average transcript level of all 6 repair genes in the panel. 186
3 chromatid breaks per cell in cases than in controls. 11,13-15 While bleomycin-induced mutagen sensitivity has an intriguing role as a cancer risk factor, it provides only indirect evidence for a role for altered DNA repair ability in cancer susceptibility. In fact, laboratory evidence linking mutagen sensitivity and DNA repair ability is scant. 12 Because there is only indirect evidence of reduced DNA repair in patients with SCCHN, we undertook a pilot project to examine components of 3 DNA repair pathways in lymphoblastoid cell lines derived from patients with SCCHN and normal donors. We also correlated the mutagen sensitivity profile of these cell lines M β-actin hmsh3 hmsh2 hpms2 hgtbp hmlh1 hpms1 Figure 1. Control multiplex reverse transcriptase polymerase chain reaction amplification of 6 genes of the mismatch repair pathway and -actin. M indicates molecular marker ( X174-RF DNA Hae III Digest; Pharmacia Biotech Inc, Piscataway, NJ); lane 1, hmsh3 gene (512 base pair [bp]) coamplified with -actin (621 bp) only; lane 2, hmsh2 gene (429 bp) coamplified with -actin only; lane 3, hpms2 gene (359 bp) coamplified with -actin only; lane 4, hgtbp gene (288 bp) coamplified with -actin only; lane 5, hmlh1 gene (215 bp) coamplified with -actin only; lane 6, hpms1 gene (174 bp) coamplified with -actin only; lane 7, all 6 mismatch repair genes coamplified with -actin. Each band is the expected size. with the values obtained from 3 DNA repair assays to further examine the mechanisms underlying mutagen sensitivity. RESULTS NUCLEOTIDE EXCISION REPAIR The host cell reactivation assay was used to assess NER. The mean (± SD) NER capacity was 25.1% ± 6.1% (range, 14.3%-33.3%) for the lymphoblastoid cell lines derived from patients with SCCHN and 26.% ± 1.8% (range, 9.4%-47.7%) for those cell lines derived from cancerfree donors (Figure 2). These differences were not statistically significant (P =.83). The 2 positive control XP-C and XP-A cell lines demonstrated deficient NER capacity (4.2% and 1.%, respectively), as expected, and the normal control cell line expressed 29% NER capacity (Figure 2). When the NER capacity value for each cell line was compared with its mutagen sensitivity value, there was a trend toward an inverse correlation (r =.44, P =.5) (Figure 3). In other words, the more mutagen sensitive the cell line, the less NER capacity it expressed. MISMATCH REPAIR A multiplex RT-PCR assay was used to measure the relative expression level of 6 MMR genes as a partial assessment of MMR. There was no difference in the expression level of these genes between the 2 groups (Figure 4). Furthermore, all the cell lines expressed all the genes measured by this assay. As expected, the positive (deficient) control cell lines LoVo and SW48 consistently did not 5 4 NER Capacity, % Cancer-Free Donors Patients With Head and Neck Cancer (NL) Avg = 26. ± 1.82 Avg = 25.5 ± 6.8 Figure 2. Nucleotide excision repair (NER) capacity (± SD indicated by range brackets) of all 2 experimental cell lines as well as normal (NL) (proficient) control cell line GM131A [131] and positive (deficient) control xeroderma pigmentosum cell lines (2246 and 2345) (XP) Controls 2345 (XP) 187
4 5 Controls M H 2 NL131 +LoVo +SW NER Capacity, % Mutagen Sensitivity, No. of Chromatid Breaks per Cell express the hmsh2 and hmlh1 gene transcripts, respectively, whereas the water and normal control (GM131A) were appropriately negative and normal, respectively (Figure 5). There was no correlation between the average or individual MMR gene transcript level and the mutagen sensitivity value for these cell lines. RECOMBINATIONAL REPAIR r =.44 P =.5 Figure 3. Analysis of correlation between nucleotide excision repair (NER) capacity and mutagen sensitivity of the 2 experimental lymphoblastoid cell lines. Relative Expression Level Cancer-Free Donors Patients With Head and Neck Cancer hmsh3 hmsh2 hpms2 hgtbp hmlh1 hpms1 Gene Figure 4. Average relative expression (± SD indicated by range brackets) of 6 mismatch repair gene transcripts in cell lines derived from patients with squamous cell carcinoma of the head and neck and cancer-free donors. The expression level of -actin (1%) was used as the internal control to calculate the relative expression. A multiplex RT-PCR assay was used to assess, in part, recombinational repair. In the cell lines derived from patients, there was elevated expression of 4 (XRCC7, XRCC6, XRCC1, and RAD51) of the 6 genes examined from this pathway (Figure 6), though the increase was statistically significant only for the XRCC7 gene (P =.3). All cell lines expressed all of these genes as measured by this assay. There was no correlation between the average transcript level of the genes involved in recombinational repair and the mutagen sensitivity value for each cell line. However, increasing XRCC4 gene levels correlated with increasing mutagen sensitivity (r =.56, P =.1), and a similar trend existed for RAD51 gene (r =.43, P =.6) (Figure 7). COMMENT β-actin hmsh3 hmsh2 hpms2 hgtbp hmlh1 hpms1 Figure 5. Multiplex reverse transcriptase polymerase chain reaction amplification in 6 genes of the mismatch repair pathway and -actin. M indicates molecular marker ( X174-RF DNA Hae III Digest, Pharmacia Biotech Inc, Piscataway, NJ); H 2 O, nuclease-free water; NL131, normal (proficient) control cell line; +LoVo, positive (deficient) control cell line (lacks hmsh2 gene transcript); +SW48, positive (deficient) control cell line (lacks hmlh1 gene transcript); 342 and 3445, cell lines derived from cancer-free donors; and 3512, cell line derived from a patient with squamous cell carcinoma of the head and neck. In this study, we explored the susceptibility to cancer (specifically, genetically determined DNA repair function) of patients with SCCHN by examining DNA repair pathways in 2 lymphoblastoid cell lines previously characterized by a cytogenetic assay of cancer susceptibility. 16 While there was no difference in the repair ability between the 2 groups (Figure 2), there was a wide range of NER capacity, consistent with a broad spectrum of susceptibility in the population. Additionally, there was no obvious absence or reduction in expression of either the MMR or recombinational repair gene transcripts in the patient cell lines (Figures 4 and 6). In fact, there appeared to be higher expression of 4 recombinational repair genes in the cell lines derived from patients. There are at least 2 mechanistic explanations for this observation of higher recombinational repair activity in the patient cell lines. It could either be a response to greater levels of intrinsic DNA damage or an attempt to compensate for a decrease in recombinational repair protein function. Further studies will be needed to compare differences in spontaneous and induced damage and to functionally assess the recombinational repair pathway in these 2 groups. However, this study has limitations. One is that it examined a small number of cell lines (but inclusive of the entire group previously reported). 16 Also, viral transformation of an individual s lymphocytes may reduce phenotypic differences in susceptibility. In fact, the difference in mutagen sensitivity between patients and cancer-free donors dropped by a factor of 2.6 after the transformation process. 16 Therefore, the utility of cell lines for evaluating cancer susceptibility may be limited, and larger patient-based studies of fresh lymphocytes will be needed to explore actual differences in cancer susceptibility. Our secondary goal was to examine the correlation between a cytogenetic assay of susceptibility (mutagen sensitivity) and 3 assays of DNA repair, to better understand the underlying mechanisms of mutagen sensitiv- 188
5 1 Cancer-Free Donors Patients With Head and Neck Cancer XRCC4 Gene: r =.56, P =.1 Relative Expression Level P =.3 XRCC7 XRCC6 XRCC1 ATM RAD51 XRCC4 Gene Figure 6. Average relative expression (± SD indicated by range brackets) of 6 recombinational repair gene transcripts in cell lines derived from patients with squamous cell carcinoma of the head and neck and cancer-free donors. The expression level of -actin (1%) was used as the internal control to calculate the relative expression. ity. Bleomycin (which is used in the mutagen sensitivity assay) primarily induces DNA strand breaks, which are believed to be repaired by the recombinational repair pathway. 22 Baseline transcript levels of some recombinational repair genes did appear to correlate with the mutagen sensitivity value (Figure 7). Interestingly, the NER capacity also appeared to correlate with the mutagen sensitivity value (Figure 3). Although this seems contradictory, one must keep in mind that there is overlap between the repair pathways both in their target lesions and in their constituent components. In fact, the ERCC1 and ERCC4 genes appear to have roles in both NER and recombinational repair. 22 Consequently, mutations in or polymorphisms of these 2 genes could affect both pathways and so lead to such a correlation between bleomycin-induced mutagen sensitivity (hypothetically due to recombinational repair) and BPDEdamaged plasmid reactivation (an NER process). However, given this rather limited correlation, we can surmise that factors in addition to DNA repair ability also contribute to a cell line s mutagen sensitivity phenotype. In conclusion, although there was no significant decrease in NER capacity or MMR transcript levels in lymphoblastoid cell lines derived from patients with SCCHN compared with those from cancer-free individuals, there was a trend toward an increase in recombinational repair transcript levels. This result may reflect limitations in the number of cell lines available or in the nature of the transformed cell line, and consequently we have recently employed these assays in much larger case-control studies using fresh lymphocytes In contrast to our results from transformed cell lines, studies of fresh lymphocytes revealed differences between control subjects and those with cancer and suggest that such assays can be used as phenotypic markers of cancer susceptibility. Secondly, the well-established mutagen sensitivity assay partially measures differences in NER capacity and recombinational repair transcript levels, but obviously other factors requiring further study contribute to this phenotypic marker of cancer susceptibility. Relative Expression Level RAD51 Gene: r =.43, P = Mutagen Sensitivity, No. of Chromatid Breaks per Cell Figure 7. Analysis of correlation between the XRCC4 (solid circles) and RAD51 (open circles) genes relative expression and mutagen sensitivity of the 2 experimental lymphoblastoid cell lines. Accepted for publication August 25, This work was supported in part by National Institutes of Health (Bethesda, Md) grants for Training of the Academic Head and Neck Surgical Oncologist T32 CA 6374 (Dr Clayman), R3 CA 7242, and R1 CA (Dr Wei). Presented at the Fifth Research Workshop on the Biology, Prevention, and Treatment of Head and Neck Cancer, McLean, Va, on August 28, From the University of Texas, Houston, we wish to thank T. C. Hsu, PhD (Department of Cell Biology), for kindly providing the lymphoblastoid cell lines used in this study and Maureen Goode, PhD (Department of Scientific Publications), for editing of the manuscript. Corresponding author: Qingyi Wei, MD, PhD, the University of Texas, M. D. Anderson Cancer Center, Department of Epidemiology, Box 189, 1515 Holcombe Blvd, Houston, TX 773 ( qwei@notes.mdacc.tmc.edu). REFERENCES 1. Office of Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. Cigarette smoking among adults United States, MMWR Morb Mortal Wkly Rep. 1994; 43: Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, CA Cancer J Clin. 1998;48: Schantz SP, Byers RM, Goepfert H, Shallenberger RC, Beddingfield N. The implication of tobacco use in the young adult with head and neck cancer. Cancer. 1988;62: Koch WM, McQuone S. Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinker. Curr Opin Oncol. 1997;9: Foulkes WD, Brunet JS, Sieh W, Black MJ, Shenouda G, Narod SA. Familial risks of squamous cell carcinoma of the head and neck: retrospective case-control study. BMJ. 1996;313: Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systemic populationbased assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 1994;86: Foulkes WD, Brunet JS, Kowalski LP, Narod SA, Franco EL. Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. Int J Cancer. 1995;63: Copper MP, Jovanovic A, Nauta JJP, et al. Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1995;121: Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase geno- 189
6 types GSTM1 and GSTM1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1997;6: Benhamou S, Bouchardy C, Paoletti C, Dayer P. Effects of CYP2D6 activity and tobacco on larynx cancer risk. Cancer Epidemiol Biomarkers Prev. 1996;5: Hsu TC, Johnston DA, Cherry LM, et al. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer. 1989;43: Wei Q, Spitz MR, Gu J, et al. DNA repair capacity correlates with mutagen sensitivity in lymphoblastoid cell lines. Cancer Epidemiol Biomarkers Prev. 1996;5: Wei Q, Gu J, Cheng L, et al. Benzo[a]pyrene diol epoxide induced chromosomal aberrations and risk of lung cancer. Cancer Res. 1996;56: Spitz MR, Fueger JJ, Beddingfield NA, et al. Chromosome sensitivity to bleomycininduced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 1989;49: Cloos J, Spitz MR, Schantz SP, et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst. 1996;88: Hsu TC, Shillitoe EJ, Cherry LM, Lin Q, Schantz SP, Furlong C. Cytogenetic characterization of 2 lymphoblastoid cell lines derived from human individuals differing in bleomycin sensitivity. In Vitro Cell Dev Biol. 199;26: Wei Q, Matanoski GM, Farmer ER, Hedayati M, Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiologic study. Proc Natl Acad Sci USA.1993;9: Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res. 1996;56: McCuchan JH, Pagano JS. Enhancement of the infectivity of simian virus 4 deoxyribonucleic acid with diethylaminoethyl-dextran. J Natl Cancer Inst. 1968;41: Wei Q, Xu X, Cheng L, Legerski R, Ali-Osman F. Simultaneous amplification of four DNA repair genes and -actin in human lymphocytes by multiplex reverse transcriptase-pcr. Cancer Res. 1995;55: Wei Q, Bondy ML, Mao L, et al. Reduced expression of mismatch repair genes measured by multiplex reverse transcription-polymerase chain reaction in human gliomas. Cancer Res. 1997;57: Thompson LH. Evidence that mammalian cells possess homologous recombinational repair pathways. Mutat Res. 1996;363: Wang LE, Sturgis EM, Eicher SA, Spitz MR, Hong WK, Wei Q. Mutagen sensitivity to benzo[a]pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res. 1998;4: Cheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1998;7: Wei Q, Eicher SA, Guan Y, et al. Reduced expression of hmlh1 and hgtbp/ hmsh6: a risk factor for head and neck cancer. Cancer Epidemiol Biomarkers Prev. 1998;7:
GLUTATHIONE-S-TRANSFERASE POLYMORPHISMS AND RISK OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Int. J. Cancer (Pred. Oncol.): 84, 220 224 (999) 999 Wiley-Liss, Inc. GLUTATHIONE-S-TRANSFERASE POLYMORPHISMS AND RISK OF SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK Publication of the International Union
More informationORIGINAL ARTICLE. DNA Repair Gene ERCC1 and ERCC2/XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck
ORIGINAL ARTICLE DNA Repair Gene ERCC1 and ERCC2/XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck Erich M. Sturgis, MD; Kristina R. Dahlstrom, BS; Margaret R. Spitz, MD, MPH;
More informationSpring 2015 Module 2 System Engineering and Protein Founda<ons
20.109 Spring 2015 Module 2 System Engineering and Protein Founda
More informationAssociation between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population
Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population R. Zhao and M.F. Ying Department of Pharmacy, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University,
More informationAssociation between ERCC1 and XPF polymorphisms and risk of colorectal cancer
Association between ERCC1 and XPF polymorphisms and risk of colorectal cancer H. Yang, G. Li and W.F. Li Departments of Radiation Oncology and Chemotherapy, The First Affiliated Hospital of Wenzhou Medical
More informationDNA Repair and Susceptibility to Basal Cell Carcinoma: A Case-Control Study
American Journal of Epidemiology Vol. 140, 7 Copyright 1994 by The Johns Hopkins University School of Hygiene and Public Health Printed in U.S.A. All rights reserved DNA Repair and Susceptibility to Basal
More informationChapter 9. Cells Grow and Reproduce
Chapter 9 Cells Grow and Reproduce DNA Replication DNA polymerase Addition of a nucleotide to the 3 end of a growing strand Use dntps as substrate Release of pyrophosphate Initiation of Replication Replication
More informationIncreased Rates of Chromosome Breakage in BRCA1 Carriers Are Normalized by Oral Selenium Supplementation
1302 Cancer Epidemiology, Biomarkers & Prevention Short Communication Increased Rates of Chromosome Breakage in BRCA1 Carriers Are Normalized by Oral Selenium Supplementation Elzbieta Kowalska, 1 Steven
More informationInterplay between mutagen sensitivity and epidemiological factors in modulating lung cancer risk
Int. J. Cancer: 120, 2687 2695 (2007) ' 2007 Wiley-Liss, Inc. Interplay between mutagen sensitivity and epidemiological factors in modulating lung cancer risk Xifeng Wu*, Jie Lin, Carol J. Etzel, Qiong
More informationAssociation of polymorphisms of the xeroderma pigmentosum complementation group F gene with increased glioma risk
Association of polymorphisms of the xeroderma pigmentosum complementation group F gene with increased glioma risk W.K. Zhou 1, L.Y. Huang 1, L. Hui 1, Z.W. Wang 1, B.Z. Jin 1, X.L. Zhao 1, X.Z. Zhang 1,
More informationCourse Title Form Hours subject
Course Title Form Hours subject Types, and structure of chromosomes L 1 Histology Karyotyping and staining of human chromosomes L 2 Histology Chromosomal anomalies L 2 Histology Sex chromosomes L 1 Histology
More informationBiochemistry 201: DNA repair January 24, 26, 2000 Gilbert Chu
1) Why study DNA repair? Biochemistry 201: DNA repair January 24, 26, 2000 Gilbert Chu The genome is assaulted by a myriad of different agents that cause DNA damage. Sources of damage can be both exogenous
More informationDepartment of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA 2
Pancreatic Cancer Cell Exosome-Mediated Macrophage Reprogramming and the Role of MicroRNAs 155 and 125b2 Transfection using Nanoparticle Delivery Systems Mei-Ju Su 1, Hibah Aldawsari 2, and Mansoor Amiji
More informationConstruction of a hepatocellular carcinoma cell line that stably expresses stathmin with a Ser25 phosphorylation site mutation
Construction of a hepatocellular carcinoma cell line that stably expresses stathmin with a Ser25 phosphorylation site mutation J. Du 1, Z.H. Tao 2, J. Li 2, Y.K. Liu 3 and L. Gan 2 1 Department of Chemistry,
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationProduct Manual. Omni-Array Sense Strand mrna Amplification Kit, 2 ng to 100 ng Version Catalog No.: Reactions
Genetic Tools and Reagents Universal mrna amplification, sense strand amplification, antisense amplification, cdna synthesis, micro arrays, gene expression, human, mouse, rat, guinea pig, cloning Omni-Array
More informationActivation of Gene Expression by Human Herpes Virus 6
Activation of Gene Expression by Human Herpes Virus 6 M. E. M. Campbell and S. McCorkindale 1 Introduction Human herpes virus type 6 (HHV-6) was first detected by Salahuddin et al. [6] and has been isolated
More informationAberrant DNA methylation of MGMT and hmlh1 genes in prediction of gastric cancer
Aberrant DNA methylation of MGMT and hmlh1 genes in prediction of gastric cancer J. Jin 1,2, L. Xie 2, C.H. Xie 1 and Y.F. Zhou 1 1 Department of Radiation & Medical Oncology, Zhongnan Hospital of Wuhan
More informationKit for assay of thioredoxin
FkTRX-02-V2 Kit for assay of thioredoxin The thioredoxin system is the major protein disulfide reductase in cells and comprises thioredoxin, thioredoxin reductase and NADPH (1). Thioredoxin systems are
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: W81XWH-08-1-0416 TITLE: Oxidative Stress, DNA Repair, and Prostate Cancer Risk PRINCIPAL INVESTIGATOR: Hua Zhao CONTRACTING ORGANIZATION: Health Research Inc. Buffalo, NY 14263 REPORT
More informationCancer. Questions about cancer. What is cancer? What causes unregulated cell growth? What regulates cell growth? What causes DNA damage?
Questions about cancer What is cancer? Cancer Gil McVean, Department of Statistics, Oxford What causes unregulated cell growth? What regulates cell growth? What causes DNA damage? What are the steps in
More informationAsingle inherited mutant gene may be enough to
396 Cancer Inheritance STEVEN A. FRANK Asingle inherited mutant gene may be enough to cause a very high cancer risk. Single-mutation cases have provided much insight into the genetic basis of carcinogenesis,
More informationSignificant Association of Ku80 Single Nucleotide Polymorphisms with Bladder Cancer Susceptibility in Taiwan
Significant Association of Ku80 Single Nucleotide Polymorphisms with Bladder Cancer Susceptibility in Taiwan CHAO-HSIANG CHANG 1,2*, CHANG-FANG CHIU 2,3*, SHIU-YUN LIANG 2*, HSI-CHIN WU 1,2, CHIA-LIN CHANG
More informationGenetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma M.J. Wang, Y. Zhu, X.J. Guo and Z.Z. Tian Department of Orthopaedics, Xinxiang Central Hospital, Xinxiang,
More informationHepatitis B Antiviral Drug Development Multi-Marker Screening Assay
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against
More informationCHAPTER 4 RESULTS. showed that all three replicates had similar growth trends (Figure 4.1) (p<0.05; p=0.0000)
CHAPTER 4 RESULTS 4.1 Growth Characterization of C. vulgaris 4.1.1 Optical Density Growth study of Chlorella vulgaris based on optical density at 620 nm (OD 620 ) showed that all three replicates had similar
More informationSupplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR
Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4
More informationRole of Paired Box9 (PAX9) (rs ) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis
EC Dental Science Special Issue - 2017 Role of Paired Box9 (PAX9) (rs2073245) and Muscle Segment Homeobox1 (MSX1) (581C>T) Gene Polymorphisms in Tooth Agenesis Research Article Dr. Sonam Sethi 1, Dr. Anmol
More informationAIDS - Knowledge and Dogma. Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/ , Vienna, Austria
AIDS - Knowledge and Dogma Conditions for the Emergence and Decline of Scientific Theories Congress, July 16/17 2010, Vienna, Austria Reliability of PCR to detect genetic sequences from HIV Juan Manuel
More informationAssociation between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer
Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer M.G. He, K. Zheng, D. Tan and Z.X. Wang Department of Hepatobiliary Surgery, Nuclear Industry 215 Hospital
More informationMutagenesis. David M. DeMarini, Ph.D. University of North Carolina at Chapel Hill.
Mutagenesis David M. DeMarini, Ph.D. University of North Carolina at Chapel Hill ddemarini@nc.rr.com 1. DNA as the Target Mutagenesis Overview 2. DNA Damage (The Mutagenesis Paradigm) A. Types of Damage
More informationHepatitis B Virus Genemer
Product Manual Hepatitis B Virus Genemer Primer Pair for amplification of HBV Viral Specific Fragment Catalog No.: 60-2007-10 Store at 20 o C For research use only. Not for use in diagnostic procedures
More informationSupplementary data Supplementary Figure 1 Supplementary Figure 2
Supplementary data Supplementary Figure 1 SPHK1 sirna increases RANKL-induced osteoclastogenesis in RAW264.7 cell culture. (A) RAW264.7 cells were transfected with oligocassettes containing SPHK1 sirna
More informationMicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells Margaret S Ebert, Joel R Neilson & Phillip A Sharp Supplementary figures and text: Supplementary Figure 1. Effect of sponges on
More informationLack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population
Lack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population J.J. Lu, H.Q. Zhang, P. Mai, X. Ma, X. Chen, Y.X. Yang and L.P. Zhang Gansu Provincial Hospital, Donggang
More informationRESISTANCE RELATIONSHIPS BETWEEN PLATINUM AND PARP-INHIBITORS IN OVARIAN CANCER.
RESISTANCE RELATIONSHIPS BETWEEN PLATINUM AND PARP-INHIBITORS IN OVARIAN CANCER. Britta Stordal 1, Yidong Chen 2, Angela Farrelly 3, Danielle Gallagher 3, Steven Busschots 1, Mattia Cremona 3, Mark Carey
More informationOnline Data Supplement. Anti-aging Gene Klotho Enhances Glucose-induced Insulin Secretion by Upregulating Plasma Membrane Retention of TRPV2
Online Data Supplement Anti-aging Gene Klotho Enhances Glucose-induced Insulin Secretion by Upregulating Plasma Membrane Retention of TRPV2 Yi Lin and Zhongjie Sun Department of physiology, college of
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationHuman Papillomavirus in Squamous Cell Carcinoma of Esophagus in a High-Risk Population
Human Papillomavirus in Esophageal Cancer Tahmasebi Fard Z Department of Molecular Biology, Khatam Postgraduate Faculty, Tehran Farhadi Langroody M Shahrara Medical Laboratory, Tehran Malekzadeh R Digestive
More informationThe Need for a PARP in vivo Pharmacodynamic Assay
The Need for a PARP in vivo Pharmacodynamic Assay Jay George, Ph.D. Chief Scientific Officer Trevigen, Inc. Gaithersburg, MD Poly(ADP-ribose) polymerases are promising therapeutic targets. In response
More informationHEK293FT cells were transiently transfected with reporters, N3-ICD construct and
Supplementary Information Luciferase reporter assay HEK293FT cells were transiently transfected with reporters, N3-ICD construct and increased amounts of wild type or kinase inactive EGFR. Transfections
More informationAssociation between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk
Association between the -77T>C polymorphism in the DNA repair gene XRCC1 and lung cancer risk B.B. Sun, J.Z. Wu, Y.G. Li and L.J. Ma Department of Respiratory Medicine, People s Hospital Affiliated to
More informationFor in vitro Veterinary Diagnostics only. Kylt Rotavirus A. Real-Time RT-PCR Detection.
For in vitro Veterinary Diagnostics only. Kylt Rotavirus A Real-Time RT-PCR Detection www.kylt.eu DIRECTION FOR USE Kylt Rotavirus A Real-Time RT-PCR Detection A. General Kylt Rotavirus A products are
More informationwhat s new? CONFERENCE ALCOHOL AND HEALTH Amsterdam, 23 September 2010
CONFERENCE ALCOHOL AND HEALTH Amsterdam, 23 September 2010 Alcohol drinking and cancer risk: what s new? Dr Paule LATINO-MARTEL UMR U 557 Inserm, U 1125 Inra, Cnam, Université Paris 13; CRNH-IdF, France
More informationSupplementary Material
Supplementary Material Nuclear import of purified HIV-1 Integrase. Integrase remains associated to the RTC throughout the infection process until provirus integration occurs and is therefore one likely
More informationIdentification of Mutation(s) in. Associated with Neutralization Resistance. Miah Blomquist
Identification of Mutation(s) in the HIV 1 gp41 Subunit Associated with Neutralization Resistance Miah Blomquist What is HIV 1? HIV-1 is an epidemic that affects over 34 million people worldwide. HIV-1
More informationEnvironmental Management & Pollution Environmental and Chemical Carcinogenesis
Environmental Management & Pollution Environmental and Chemical Carcinogenesis 8.1 Abstract People are continuously exposed exogenously to varying amounts of chemicals that have been shown to have carcinogenic
More informationApplication of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma
Excerpt from MACS&more Vol 8 1/2004 Application of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma L. Davis Lupo and Salvatore T. Butera HIV and Retrovirology Branch,
More informationValidation Report: VERSA Mini PCR Workstation Reverse Transcription of Avian Flu RNA and Amplification of cdna & Detection of H5N1
I. Objectives Validation Report: VERSA Mini PCR Workstation Reverse Transcription of Avian Flu RNA and Amplification of cdna & Detection of H5N1 1. To ensure stability of RNA (highly thermolabile and degradatively
More informationNeoplasia. (4&5 of 6)
Neoplasia (4&5 of 6) Carcinogenic agents 3 major classes: -Chemicals -Radiation -Microbes Chemicals Direct-Acting Chimney sweeps and chronic exposure to soot or Indirect-Acting Direct-Acting chemical carcinogens
More informationTitle: DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study
Author's response to reviews Title: DNA repair gene polymorphisms and risk of chronic atrophic gastritis: a case-control study Authors: Bernd Frank (b.frank@dkfz.de) Heiko Müller (h.mueller@dkfz.de) Melanie
More informationChapter 2. Review of Literature
Chapter 2 The yet undeciphered extraordinary complexity of the disease cancer has remained the Achilles heel of scientific progress for many decades. This disease with countable names, but uncountable
More informationPG-Seq NGS Kit for Preimplantation Genetic Screening
Application Note: PG-Seq Validation Study PG-Seq NGS Kit for Preimplantation Genetic Screening Validation using Multi (5-10) Cells and Single Cells from euploid and aneuploid cell lines Introduction Advances
More informationChapter 18. Viral Genetics. AP Biology
Chapter 18. Viral Genetics 2003-2004 1 A sense of size Comparing eukaryote bacterium virus 2 What is a virus? Is it alive? DNA or RNA enclosed in a protein coat Viruses are not cells Extremely tiny electron
More informationMTC-TT and TPC-1 cell lines were cultured in RPMI medium (Gibco, Breda, The Netherlands)
Supplemental data Materials and Methods Cell culture MTC-TT and TPC-1 cell lines were cultured in RPMI medium (Gibco, Breda, The Netherlands) supplemented with 15% or 10% (for TPC-1) fetal bovine serum
More informationSmoke Like a Man, Survive Like a Woman
Smoke Like a Man, Survive Like a Woman Sex Specific Differences in Lung Cancer Pulmonary Grand Rounds Philippe R. Montgrain, M.D. May 1, 2008 Objectives 1. Review how lung cancer differs in men and women.
More informationMulti-clonal origin of macrolide-resistant Mycoplasma pneumoniae isolates. determined by multiple-locus variable-number tandem-repeat analysis
JCM Accepts, published online ahead of print on 30 May 2012 J. Clin. Microbiol. doi:10.1128/jcm.00678-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Multi-clonal origin
More informationTransfection of Sf9 cells with recombinant Bacmid DNA
Transposition Bacmid DNA Mini Culturing baculo cells Transfection of Sf9 cells with recombinant Bacmid DNA Amplification of the virus Titration of baculo stocks Testing the expression Transposition 1.
More informationDATA SHEET. Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA.
Viral Load DNA >> Standard PCR standard 0 Copies Catalog Number: 1122 Lot Number: 150298 Release Category: A Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter
More informationCYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women
CYP19 gene polymorphisms and the susceptibility to breast cancer in Xinjiang Uigur women L. Yang, X.Y. Wang, Y.T. Li, H.L. Wang, T. Wu, B. Wang, Q. Zhao, D. Jinsihan and L.P. Zhu The Department of Mammary
More informationCharacterization of the DNA-mediated Oxidation of Dps, a Bacterial Ferritin
SUPPORTING INFORMATION Characterization of the DNA-mediated Oxidation of Dps, a Bacterial Ferritin Anna R. Arnold, Andy Zhou, and Jacqueline K. Barton Division of Chemistry and Chemical Engineering, California
More informationInternational Agency for Research on Cancer (IARC) - Summaries & Evaluations
International Agency for Research on Cancer (IARC) - Summaries & Evaluations AFLATOXINS Naturally Occurring Aflatoxins (Group1) Aflatoxin M1 (Group 2B) For definition of Groups, see Preamble Evaluation.
More informationR. Balansky 1,2, F. D Agostini 2, A. Izzotti 2, P. Kalpakam 3, V.E. Steele 4, S. De Flora 2
INCON / 10 ICMAA, Guarujà, Brazil, September 26-29, 2010 MECHANISMS OF INHIBITION OF CIGARETTE SMOKE GENOTOXICITY AND CARCINOGENICITY 1 2 3 4 R. Balansky 1,2, F. D Agostini 2, A. Izzotti 2, P. Kalpakam
More informationViruses Tomasz Kordula, Ph.D.
Viruses Tomasz Kordula, Ph.D. Resources: Alberts et al., Molecular Biology of the Cell, pp. 295, 1330, 1431 1433; Lehninger CD Movie A0002201. Learning Objectives: 1. Understand parasitic life cycle of
More informationInt J Clin Exp Med 2015;8(2): /ISSN: /IJCEM
Int J Clin Exp Med 2015;8(2):2934-2938 www.ijcem.com /ISSN:1940-5901/IJCEM0003510 Original Article Correlation of rs1799793 polymorphism in ERCC2 and the clinical response to platinum-based chemotherapy
More informationKaryotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl
Chapt. 18 Cancer Molecular Biology of Cancer Student Learning Outcomes: Describe cancer diseases in which cells no longer respond Describe how cancers come from genomic mutations (inherited or somatic)
More informationCytochrome P450 2E1 RsaI/PstI and DraI Polymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han Population in Inner Mongolia
www.springerlink.com Chin J Cancer Res 23(2): 107-111, 2011 107 Original Article Cytochrome 450 2E1 RsaI/stI and DraI olymorphisms Are Risk Factors for Lung Cancer in Mongolian and Han opulation in Inner
More informationExample: Distance in M.U. % Crossing Over Why? Double crossovers
Example: Distance in M.U. % Crossing Over 1 5 10 15 50 80 100 107 Why? Double crossovers 232 .. A B. a b. 1. A fully heterozygous gray-bodied (b+), normal winged (vg+) female F 1 fruit fly crossed with
More informationBlocking the expression of the hepatitis B virus S gene in hepatocellular carcinoma cell lines with an anti-gene locked nucleic acid in vitro
Blocking the expression of the hepatitis B virus S gene in hepatocellular carcinoma cell lines with an anti-gene locked nucleic acid in vitro Y.-B. Deng, H.-J. Qin, Y.-H. Luo, Z.-R. Liang and J.-J. Zou
More informationAnnexure III SOLUTIONS AND REAGENTS
Annexure III SOLUTIONS AND REAGENTS A. STOCK SOLUTIONS FOR DNA ISOLATION 0.5M Ethylene-diamine tetra acetic acid (EDTA) (ph=8.0) 1M Tris-Cl (ph=8.0) 5M NaCl solution Red cell lysis buffer (10X) White cell
More informationAmerican Journal of EPIDEMIOLOGY
Volume 161 Number 1 January 1, 2005 American Journal of EPIDEMIOLOGY Copyright 2005 by The Johns Hopkins Bloomberg School of Public Health Sponsored by the Society for Epidemiologic Research Published
More informationENVIRONMENTAL FACTORS IN VIRUS-ASSOCIATED HUMAN CANCERS
ENVIRONMENTAL FACTORS IN VIRUS-ASSOCIATED HUMAN CANCERS Joint Graduate Seminar Depar tment of Microbiology The Chinese University of Hong Kong PhD Candidate: Zhang Chuqing Super visor: Professor Paul Chan
More informationOriginal Policy Date
MP 2.04.76 Genetic Counseling Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Created Local Policy/ 12:2013 Return to Medical Policy Index Disclaimer
More informationMRC-Holland MLPA. Description version 29;
SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,
More informationBladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle Control Genes
Bladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle Control Genes Xifeng Wu, 1 Jian Gu, 1 H. Barton Grossman, 2 Christopher I. Amos, 1 Carol Etzel, 1 Maosheng Huang, 1 Qing
More informationMarijuana Use and Increased Risk of Squamous Cell Carcinoma of the Head and Neck 1
Vol. 8, 1071 1078, December 1999 Cancer Epidemiology, Biomarkers & Prevention 1071 Marijuana Use and Increased Risk of Squamous Cell Carcinoma of the Head and Neck 1 Zuo-Feng Zhang, 2 Hal Morgenstern,
More informationInvestigation of the role of XRCC1 genetic polymorphisms in the development of gliomas in a Chinese population
Investigation of the role of XRCC1 genetic polymorphisms in the development of gliomas in a Chinese population S.C. Fan 1, J.G. Zhou 2 and J.Z. Yin 1 1 Department of Neurosurgery, The People s Hospital
More informationPolymorphisms of XPC Gene And Susceptibility of Esophageal Cancer
www.springerlink.co Chin J Cancer Res 22(1):49-54, 2010 49 Original Article Polymorphisms of XPC Gene And Susceptibility of Esophageal Cancer Xiang-xian Feng 1, 2, Pei-fen Duan 2, Li-bing Wang 2, Zu-xun
More informationInvestigating the role of polymorphisms in mir-146a, -149, and -196a2 in the development of gastric cancer
Investigating the role of polymorphisms in mir-146a, -149, and -196a2 in the development of gastric cancer Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong
More informationPurification and Fluorescent Labeling of Exosomes Asuka Nanbo 1*, Eri Kawanishi 2, Ryuji Yoshida 2 and Hironori Yoshiyama 3
Purification and Fluorescent Labeling of Exosomes Asuka Nanbo 1*, Eri Kawanishi 2, Ryuji Yoshida 2 and Hironori Yoshiyama 3 1 Graduate School of Medicine, Hokkaido University, Sapporo, Japan; 2 Graduate
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationExtracellular Vesicle RNA isolation Kits
Extracellular Vesicle RNA isolation Kits Summary Section 4 Introduction 42 Exo-TotalRNA and TumorExo-TotalRNA isolation kits 43 Extracellular Vesicle RNA extraction kits Ordering information Products can
More informationSupplementary Information. Supplementary Figure 1
Supplementary Information Supplementary Figure 1 1 Supplementary Figure 1. Functional assay of the hcas9-2a-mcherry construct (a) Gene correction of a mutant EGFP reporter cell line mediated by hcas9 or
More informationCancer Biomarkers and Susceptibility Factors. Thomas Kensler, PhD Bloomberg School of Public Health
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this
More informationPhosphate buffered saline (PBS) for washing the cells TE buffer (nuclease-free) ph 7.5 for use with the PrimePCR Reverse Transcription Control Assay
Catalog # Description 172-5080 SingleShot Cell Lysis Kit, 100 x 50 µl reactions 172-5081 SingleShot Cell Lysis Kit, 500 x 50 µl reactions For research purposes only. Introduction The SingleShot Cell Lysis
More informationA protocol for enhancement of the AAV-mediated expression of transgenes
A protocol for enhancement of the AAV-mediated expression of transgenes Hiroaki Mizukami, Takeharu Kanazawa, Takashi Okada, and Keiya Ozawa Division of Genetic Therapeutics, Center for Molecular Medicine,
More informationDownregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases
Brief Communication Downregulation of serum mir-17 and mir-106b levels in gastric cancer and benign gastric diseases Qinghai Zeng 1 *, Cuihong Jin 2 *, Wenhang Chen 2, Fang Xia 3, Qi Wang 3, Fan Fan 4,
More informationLESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication
DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit
More informationEpidemiology, Pathogenesis, and Prevention of Head and Neck Cancer
Epidemiology, Pathogenesis, and Prevention of Head and Neck Cancer Andrew F. Olshan Editor Epidemiology, Pathogenesis, and Prevention of Head and Neck Cancer Editor Andrew F. Olshan, Ph.D. Professor and
More informationNorgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product # 33840 Product Insert Background Information
More informationreads observed in trnas from the analysis of RNAs carrying a 5 -OH ends isolated from cells induced to express
Supplementary Figure 1. VapC-mt4 cleaves trna Ala2 in E. coli. Histograms representing the fold change in reads observed in trnas from the analysis of RNAs carrying a 5 -OH ends isolated from cells induced
More informationNorgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product# 33840 Product Insert Intended
More informationAli Alabbadi. Bann. Bann. Dr. Belal
31 Ali Alabbadi Bann Bann Dr. Belal Topics to be discussed in this sheet: Particles-to-PFU Single-step and multi-step growth cycles Multiplicity of infection (MOI) Physical measurements of virus particles
More informationPart II Underlying Scientific Principles
Part II Underlying Scientific Principles Chapter 4 Essentials of Genetics.................................................... 45 Chapter 5 Principles of Genetic Testing.............................................
More informationOriginal Article ERCC5 rs polymorphism is the risk factor for sporadic breast cancer in Thailand
Int J Mol Epidemiol Genet 2018;9(4):27-33 www.ijmeg.org /ISSN:1948-1756/IJMEG0077982 Original Article ERCC5 rs751402 polymorphism is the risk factor for sporadic breast cancer in Thailand Malinee Pongsavee
More informationRepair of Broken Chromosomes and Maintenance of Chromosome Stability
Repair of Broken Chromosomes and Maintenance of Chromosome Stability Jim Haber Brandeis University Genome instability in tumor cells Truncations Translocations Inversions Duplications Amplifications Deletions
More informationIntroduction to Cancer Biology
Introduction to Cancer Biology Robin Hesketh Multiple choice questions (choose the one correct answer from the five choices) Which ONE of the following is a tumour suppressor? a. AKT b. APC c. BCL2 d.
More informationGraveley Lab shrna knockdown followed by RNA-seq Biosample Preparation and Characterization Document
Graveley Lab shrna knockdown followed by RNA-seq Biosample Preparation and Characterization Document Wet Lab: Sara Olson and Lijun Zhan Computational Lab: Xintao Wei and Michael Duff PI: Brenton Graveley
More information6.3 DNA Mutations. SBI4U Ms. Ho-Lau
6.3 DNA Mutations SBI4U Ms. Ho-Lau DNA Mutations Gene expression can be affected by errors that occur during DNA replication. Some errors are repaired, but others can become mutations (changes in the nucleotide
More informationA Novel in Vitro Replication System for Dengue Virus
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 274, No. 47, Issue of November 19, pp. 33714 33722, 1999 1999 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. A Novel in
More information